Joseph J.Y. Sung, MD et al. Am J Gastroenterol 2010;105. R3 김민경.

Slides:



Advertisements
Similar presentations
COLORECTAL BLEEDING: A MULTIDISCIPLINARY APPROACH PATIENTS EVALUATION AND DIAGNOSIS: COLONSCOPY Stefania Caronna MD Dept. of Gastroenterology Molinette.
Advertisements

Basics of GI Bleeding Ron Thomas, MD Fellow Division of Gastroenterology and Hepatology.
Pablo M. Bedano M.D. Community Regional Cancer Care.
Acute Upper Gastrointestinal Hemorrhage “Surgical Perspective”
Teaching Liver cirrhosis with varices. Discussion  Approximately half of patients with cirrhosis have esophageal varices  One-third of all patients.
UPPER GASTROINTESTINAL BLEEDING
“Influence of Stroke Subtype on Quality of Care in The Get With The Guidelines-Stroke Program” Eric E. Smith, MD, MPH; Li Liang PhD; Adrian F Hernandez,
Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients treated with Percutaneous Coronary Intervention. Relationship with Gene.
Management of Acute Bleeding from a Peptic Ulcer
Peptic ulcer bleeding Incidence and associated mortality rate.
CMS Core Measures Evidence-Based Performance Measurement.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
Centre Cérébrovasculaire COMORBIDITY ANALYSIS AND 3 MONTHS FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE: DATA FROM ACUTE STROKE REGISTRY AND ANALYSIS.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
1 25th ECCMID , Munich, Germany Magnitude of bacteremia predicts one-year mortality Kim O. Gradel 1, Henrik C. Schønheyder 1,2, Mette Søgaard 1,
Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.
Dr Jessie Chan CMC Joint Hospital Surgical Grand Round 21 Apr 2012.
Predicting Patients at Risk for Poor Global Outcomes after DT- MCS Therapy Suzanne V. Arnold, MD, MHA Saint Luke’s Mid America Heart Institute/UMKC May.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Sarah Struthers, MD March 19, 2015
PREDICTING AKI IS MORE CHALLENGING AS AGE PROGRESSES Sandra Kane-Gill, PharmD, MSc Associate Professor, School of Pharmacy.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Coordinator: Dr. Anca Negovan Author: Andreea Bianca Stoica Co-authors: Drd. Monica Pantea Adrian Stoica Roxana Spac Gavriela Radoiu.
Blatchford score is a useful tool for predicting the need for intervention in cancer patients with upper gastrointestinal bleeding. Ahn S, Lim KS, Lee.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Gastrointestinal Review Highlights of the VIGOR Trial Lawrence Goldkind M.D.
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
Will This Admission Help? Leonard Hock, D.O., CMD Covenant Hospice.
Interventional angiography Initial success rates for patients with acute peptic ulcer bleeding are between %, with recurrent bleeding rates of 10.
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder) DR NORITA YASMIN MORNING READ 19/9/13 1.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
Decreasing Incidence of Cardiogenic Shock Summary and Comment by J. Stephen Bohan, MD, MS, FACP, FACEP Published in Journal Watch Emergency Medicine December.
AUTHOR: MORAR ANICUȚA IONELA COORDINATOR: COPOTOIU MONICA COAUTHOR: ROMAN NICOLETA GRANCEA IULIA.
IRIS Post-hoc Analysis Background IRIS compared the safety and efficacy of early ICD implantation with medical treatment alone in 898 patients at high.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
Copenhagen University Hospital Rigshospitalet, Denmark
Medical Management of Claudication: Just Walk it Off!!
以多重死因資料比較台灣美國腦中風 併發吸入性肺炎之趨勢 奇美醫學中心 張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.
The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal.
Sravanthi Parasa, MD, Udayakumar Navaneethan, MD, Arun Raghav Mahankali Sridhar, MD, MPH, Preethi G.K. Venkatesh, MD, Kevin Olden, MD Volume 77, No. 4.
Predicting Mortality in Non-Variceal Upper Gastrointestinal Bleeders: Validation of the Italian PNED Score and Prospective Comparison With the Rockall.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users C. Sostres, MD, P. Carrera-Lasfuentes, PhD, R. Benito,
Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions FOOK–HONG NG, SIU–YIN WONG, KWOK–FAI LAM,
Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study 소화기 내과 R1 박지윤 Ofke S.
JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Sex Differences in Hospital Mortality in Adults With.
Acute Renal Failure in Aneurysmal Subarachnoid Hemorrhage: Nationwide Analysis of Hospitalizations in the United States Kavelin Rumalla 1, Adithi Y. Reddy.
Introduction Upper gastrointestinal bleeding (UGIB)
Am J Gastroenterol 2012; 107:405–410 Fellow : Kim Jung Wook.
R1. 최태웅 / Pf. 김정욱. INTRODUCTION Acute upper gastrointestinal bleeding (AUGIB) : incidence of 50–150 cases/100,000 : outcomes → by preexisting comorbidity,
1 R1 임준욱 Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation.
Matt Warren. Gastroenterology North Tyneside Hospital
Outcome of between weekend/weekday hospital
Surgical ICU, Heart Institute University of São Paulo
Non-Variceal Upper GI Bleeding in Patients Already Hospitalized for Another Condition Tanja Muller, MD, Alan N. Barkun, MD, CM, MSc, Myriam Martel , BSc.
Women, Bleeding, and Coronary Intervention
Reporter : R1 林柏任.
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
Dr gavidel Journal club govaresh DR GAVIDEL
Nutrition management for peptic ulcer
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Sa1895 ENDOSCOPIC STRICTUROTOMY VS SURGICAL RE-RESECTION IN THE TREATMENT OF ANASTOMOTIC STRICTURES IN CROHN’S DISEASE  Nan Lan, Bo Shen  Gastrointestinal.
Global Registry of Acute Coronary Events: GRACE
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Management of Acute Bleeding from a Peptic Ulcer
Presentation transcript:

Joseph J.Y. Sung, MD et al. Am J Gastroenterol 2010;105. R3 김민경

Peptic ulcer Peptic ulcer  Incidence is declining but peptic ulcer bleeding(PUB) remains a major prevalent and clinically significant condition world wide. the mortality associated with PUB stays at around 5-10%  Despite advances in treatment in PUB, the mortality associated with PUB stays at around 5-10%  PUB is now predominantly a disease of the elderly  more comorbid illness, more users of aspirin/NSAIDs, less tolerant of hemodynamic insult The outcome of most studies about PUB intervention:  Recurrent bleeding, repeated endoscopic therapy, surgery, transfusion Ultimate aim of treatment of gastrointestinal bleeding is to save lives  It is important to elucidate the causes of death in PUB The aim of this study is to investigate the cause of death in PUB patients Ulcer bleeding GI cause Non-GI cause mortality

Study population: Study population: patient of the Prince of Wales Hospital Date base: Date base: UGIB registry  Demographic information, characteristics of bleeding pathologies, pharmacological, endoscopic, or surgical treatment  Admitted for PUB or developed bleeding after admission for other medical conditions  Ulcer location, stigmata of recent hemorrhage, nature and number of comorbid illness, H.pylori, medication(H2B, PPI, NSAIDs, aspirin, clopidogrel), hemodynamic status, endoscopic treatment, occurrence of rebleeding Primary outcomemortality within 30days after index bleeding Primary outcome: mortality within 30days after index bleeding  Any cause of death within 30days after index bleeding (in or out of hospital after discharge)  Cause of mortality  (A) bleeding related death  (B) non-bleeding related death

1993~ ,508 UGIB episodes PUB 10,428 cases(9,375pts) Death: 612 pts(6.5%) (during Hospital stay or within 30days after index endoscopy) Death: 577(6.2%) (within 30 days after index endoscopy) 1.Characteristics of patients 2.Cause of death of 577pts 3.Univariate analysis between bleeding and non-bleeding related mortality 4.Multivariate analysis

Characteristics of patients

Bleeding related(n=106) 29.2%(n=31) Uncontrolled bleeding/Rebleeding 25.5% (n=27) Within 48 h after endoscopy circulatory failure 2.8% (n=3) During surgery for Uncontrolled bleeding 29.2%(n=31) Surgical complications or within 1 month after surgery without other cause 13.2% (n=14) Endoscopy-related Complication Cause of death within 30days after index bleeding 50.0% of patients in the bleeding related mortality group and 28.9% patients in the non-bleeding related mortality group died within 3 days of index bleeding (P<0.001) *11pts were unclassified

Non bleeding related(n=460) 13.5% (n=62) Cardiac diseases (e.g., ACS, heart failure) 23.5% (n=108) Pulmonary diseases (ex.COPD, pneumonia) 23.9% (n=110) Multi-organ failure 5.4% (n=25) Neurological diseases (ex. stroke) 33.7%(n=155) Terminal malignancy Cause of death within 30days after index bleeding *11pts were unclassified There were significantly more patients who died of non-ulcer bleeding causes(79.7%) than bleeding cause(18.4%)

Univariate analysis between bleeding and non- bleeding related mortality

Multivariate analysis between bleeding and non-bleeding related mortality These were found to be an independent variable predicting bleeding related death

13.3~39.4% No trend incidence of bleeding and non-bleeding related mortality

1.Characteristics of patients(Surviving patients) : younger, less severe comorbid illness, more to have a previous history of ulcer and H. pylori infection, more clean based ulcer : less to be users of H2bloker/PPI and NSAIDs/aspirin, less hemodynamic shock and clinical rebleeding 2.Cause of death of 577pts : non-bleeding related – 80% : bleeding related group – 18% 3.Univariate analysis between bleeding and non-bleeding related mortality : bleeding related - older, more ulcer history, more NSAID or aspirin, with hemodynamic shock, actively bleeding ulcer : Not significant - recurrent bleeding, repeated endoscopic therapy 4.Multivariate analysis between bleeding and non-bleeding related : predicting bleeding related death - NSAIDs, aspirin, endoscopic appearance of ulcer, hemodynamic shock

Although the incidence of PUB has decrease, mortality has remained constant despite the advances in endoscopic and pharmacological therapies This study indicate that most PUB linked deaths are not direct sequelae of the bleeding ulcer itself Mortality(80%) derives from non-bleeding cause(ex. MOF, cardiopulmonary conditions, or terminal malignancy) This results is paramount for the implementation of strategies that provide supportive care and prevent complications and key organ failure, as well as treat the ulcer Future studies should be directed to explore ways to improve the over all outcome of the patients

임상 및 내시경 범주를 이용해서 재출혈과 사망의 위험도를 예측한다 5~7 점 이상인 경우, 일반적으로, 재출혈과 사망 위험이 높다

내시경 소견으로 재출혈 경향을 예측하는데 이용 Ⅰ A~ Ⅱ A: 고위험군, 내시경 치료 필요함 Ⅱ B: ?? Ⅱ C~ Ⅲ : 저위험군 병변으로 내시경 지혈술이 권고 되지 않는다.

혈색소 수치, 혈압, 맥박수의 변화 정 도 및 흑색변, 간 질환, 심장 질환 등의 존재여부에 따라 점수화 하여 0~23 의 범위를 가 지며 숫자가 높을 수록 재출혈과 사 망률의 위험도를 알수 있게 하였다.

(A1) uncontrolled bleeding (A2) within 48h after endoscopy (A3) during surgery for uncontrolled bleeding (A4) surgical complications or within 1 month after surgery (A5) endoscopic related mortality (B1) cardiac cause (B2) pulmonary causes (B3) cerebrovascular disease (B4) multi-organ failure (B5) terminal malignancy